Elsevier

Virology

Volume 167, Issue 1, November 1988, Pages 113-124
Virology

Extensive antigenic heterogeneity of foot-and-mouth disease virus of serotype C

https://doi.org/10.1016/0042-6822(88)90060-8Get rights and content

Abstract

The antigenic behavior of 46 field isolates of foot-and-mouth disease virus (FMDV) of serotype C has been studied with a panel of 24 monoclonal antibodies (MAbs) prepared against FMDV C1 or FMDV C3 Indaial. Reactivities were assayed by immunodot, immunoelectrotransfer blot, and neutralization of infectivity. The epitopes recognized by the 10 nonneutralizing MAbs are conserved in all isolates analyzed. In contrast, extreme antigenic heterogeneity is documented with regard to reactivity with 14 MAbs that, on this basis, define at least 12 epitopes involved in neutralization of FMDV of serotype C. The 31 isolates from South America were divided into 17 distinct antigenic groups and the 15 isolates from Europe into 7 groups. Lack of correspondence between antigenic composition and the origin—date and place of isolation—of the viruses was noted in several instances. Antigenic heterogeneity is shown among epidemiologically closely related FMDVs. In most—but not all—cases tested, a good correlation was found between binding of a neutralizing MAb to virions and its ability to neutralize infectivity. It is concluded that variation of epitopes involved in neutralization of FMDV is extensive among subtypes of serotype C and also among individual isolates of one subtype.

References (40)

  • J.W. Stave et al.

    Neutralization sites of type O1 foot-and-mouth disease virus defined by monoclonal antibodies and neutralization-escape virus variants

    Virology

    (1988)
  • A. Alonso Fernández et al.

    Serological and immunological relationships among type A foot-and-mouth disease strains in South America

  • P. Auge De Mello

    Plaque-reduction neutralization test for the assay of antibodies against foot-and-mouth disease

    Bull. Centro Panamericano Fiebre Aftosa

    (1976)
  • H.L. Bachrach

    Foot-and-mouth disease virus

    Annu. Rev. Microbiol.

    (1968)
  • H.L. Bachrach et al.

    Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus

    J. Immnol.

    (1975)
  • H.L. Bachrach et al.

    Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavage

    Intervirology

    (1979)
  • E. Beck et al.

    Subtyping of European FMDV outbreak strains by nucleotide sequence determination

    J. Virol.

    (1987)
  • J.L. Bittle et al.

    Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence

    Nature (London)

    (1982)
  • B.E. Clarke et al.

    Improved immunogenicity of a peptide epitope after fusion to hepatitis B core protein

    Nature (London)

    (1987)
  • R. DiMarchi et al.

    Protection of cattle against foot-and-mouth disease by a synthetic peptide

    Science

    (1986)
  • Cited by (87)

    • Inherent biophysical stability of foot-and-mouth disease SAT1, SAT2 and SAT3 viruses

      2019, Virus Research
      Citation Excerpt :

      The degree to which immunity induced by one virus is effective against another is largely dependent on the antigenic differences between them. Foot-and-mouth disease (FMD) virus (FMDV), a member of the genus Aphthovirus within the family Picornaviridae, is an example of an antigenically variable pathogen with the capacity to evade the immune response (Martínez et al., 1992; Mateu et al., 1988). FMD remains one of the most economically important diseases of livestock, such as cattle, sheep, pigs and goats (Gibbs, 1981; Sutmoller et al., 2003; Perry and Rich, 2007).

    • Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I: C)

      2014, Veterinary Microbiology
      Citation Excerpt :

      In these cases, cellular immunity may have an important function against viral infection. Low immunogenicity and weakness of cross-protection are the major drawbacks for peptide or epitope-based protein vaccines (Mateu et al., 1988; Francis et al., 1990; Sin and Weiner, 2000; Mayr, 2001; Trumpfheller et al., 2012). Thus, combining a multi-epitope protein with a potent cellular immune stimulator may be an effective strategy to broaden cross-protection and improve the immunogenicity of epitope-based vaccines.

    • Improved neutralising antibody response against foot-and-mouth-disease virus in mice inoculated with a multi-epitope peptide vaccine using polyinosinic and poly-cytidylic acid as an adjuvant

      2012, Journal of Virological Methods
      Citation Excerpt :

      The hypervariability of the immunodominant G–H loop domain has been a major drawback of VP1-based immunogens. Amino acid substitutions in the G–H loop domain alter the interaction of FMDV with neutralising antibodies (Taboga et al., 1997; Mateu et al., 1988; Francis et al., 1990). The alteration occurs when the loop epitope of a vaccine does not match that of a virus causing an FMD outbreak.

    • Quasispecies as a matter of fact: Viruses and beyond

      2011, Virus Research
      Citation Excerpt :

      Virologists presently use the term quasispecies to mean distributions of non-identical but related genomes subjected to a continuous process of genetic variation, competition, and selection, and which act as a unit of selection (Domingo, 2006; Perales et al., 2010). Following the Qβ work, quasispecies dynamics was documented with foot-and-mouth disease virus in cell culture and in vivo (Domingo et al., 1980; Sobrino et al., 1983), including the concept that antigenic heterogeneity was a consequence of genetic heterogeneity (Mateu et al., 1987, 1988, 1989; review in Domingo et al., 2003). In parallel, Holland and his colleagues interpreted the competition-selection dynamics between vesicular stomatitis virus (VSV) and their corresponding defective-interfering (DI) particles in the light of high mutation rates and quasispecies dynamics (Holland, 1984; Holland et al., 1982; Semler and Holland, 1979; Spindler et al., 1982).

    View all citing articles on Scopus
    2

    Present address: Division of Viral Diseases, Center for Infectious Diseases, Centers for Disease Control, Public Health Service, U.S. Department of Health and Human Services, Atlanta, GA 30333.

    View full text